Dassault Systemes in talks to buy drug trial software firm ArisGlobal, FT reports

July 16 : French software maker Dassault Systemes is in talks to buy drug-trial software maker ArisGlobal from Nordic Capital for about $2 billion, the Financial Times reported on Thursday, citing people familiar with the matter.• The potential deal would extend Dassault Systemes' foray into software used i

Raccontata dachannelnewsasia.com